These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 492631)

  • 1. MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) given during pregnancy.
    Jones RT; Weinerman BH
    Obstet Gynecol; 1979 Oct; 54(4):477-8. PubMed ID: 492631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy of Hodgkin disease in children.
    Kolygin BA; Fedoreev GA
    Neoplasma; 1975; 22(2):225-30. PubMed ID: 1161118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ Long-term evaluation of the effect of a chemotherapy protocol using vincristine, adriamycin, procarbazine and prednisone (VAPP) on advanced Hodgkin's disease].
    Marinone G; Colle R; Mombelloni P
    Minerva Med; 1978 Apr; 69(18):1255-61. PubMed ID: 662153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Canellos GP
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin's disease; tracheoesophageal fistula during MOPP chemotherapy.
    Weiner MJ; Sicular A; Blaugrund SM; Sattler SM
    N Y State J Med; 1981 Sep; 81(10):1509-11. PubMed ID: 6944619
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.
    Bonadonna G; Santoro A; Bonfante V; Valagussa P
    Cancer Treat Rep; 1982 Apr; 66(4):881-7. PubMed ID: 6176323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new combination chemotherapy for recurrent Hodgkin's lymphoma.
    Rahim MA; Sarma SK; Ahmed Q
    Bangladesh Med Res Counc Bull; 1982 Dec; 8(2):63-7. PubMed ID: 6897860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Four cases of Hodgkin's disease treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride].
    Kozai Y; Ohyama T; Kodo H; Tomori G
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2407-9. PubMed ID: 1281397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease.
    Cunningham J; Mauch P; Rosenthal DS; Canellos GP
    Cancer Treat Rep; 1982 Apr; 66(4):1015-22. PubMed ID: 7074629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy in Hodgkin's disease.
    Nordentoft AM; Jensen KB
    Dan Med Bull; 1973 Mar; 20(2):52-60. PubMed ID: 4688460
    [No Abstract]   [Full Text] [Related]  

  • 12. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of advanced malignant lymphomas comparative evaluation of results with single agent and combination therapy.
    Klener P; Donner L; Roth Z
    Neoplasma; 1976; 23(3):315-22. PubMed ID: 958533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy.
    Diehl LF; Perry DJ; Terebelo H; Baldwin PE; Hurwitz M; Kimball DB; Dorn RV
    Cancer Treat Rep; 1983 Sep; 67(9):827-9. PubMed ID: 6883360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal renal malformation following treatment of Hodgkin's disease during pregnancy.
    Mennuti MT; Shepard TH; Mellman WJ
    Obstet Gynecol; 1975 Aug; 46(2):194-6. PubMed ID: 1153150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of malignant lymphoma].
    Horikoshi N; Ogawa M
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1903-10. PubMed ID: 6985187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-Hodgkin's lymphoma and pregnancy treated with chemotherapy. Report of a case].
    Amaro A; Beristain C; Cárdenas JL; Mancera VJ; Ramírez G
    Ginecol Obstet Mex; 1981 Feb; 49(292):117-21. PubMed ID: 6895203
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology group.
    Glick JH; Barnes JM; Bakemeier RF; Prosnitz LR; Bennett JM; Neiman RS; Costello W; Orlow EL
    Cancer Treat Rep; 1982 Apr; 66(4):855-70. PubMed ID: 7042087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined cyclic treatment of generalized Hodgkin's disease by the MOPP program. Preliminary results and observed complications].
    Mazurowa A; Krykowski E; Pluzańska A; Dmochowska M; Robak T; Polkowska-Kulesza E; Skorek TO; Fajndt S; Boguszewska E
    Pol Tyg Lek; 1977 Apr; 32(14):521-3. PubMed ID: 854465
    [No Abstract]   [Full Text] [Related]  

  • 20. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.